These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25151429)

  • 1. Cystic fibrosis-related diabetes: a distinct condition.
    Cano Megías M; González Albarrán O
    Endocrinol Nutr; 2015 Jan; 62(1):38-44. PubMed ID: 25151429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
    Moheet A; Moran A
    Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystic fibrosis diabetes in adult].
    Vantyghem MC; Moussaïd-Guennoun R; Perimenis P; Marcelli-Tourvieille S; Perez T; Wallaert B
    Ann Endocrinol (Paris); 2005 Sep; 66(4):347-54. PubMed ID: 16392185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: how, when, why.
    Franzese A; Mozzillo E; Fattorusso V; Raia V; Valerio G
    Acta Diabetol; 2015 Aug; 52(4):633-8. PubMed ID: 25863781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benefits in lung function and nutritional status of strict metabolic control of cystic fibrosis-related diabetes.
    Martín-Frías M; Máiz L; Carcavilla A; Barrio R
    Arch Bronconeumol; 2011 Oct; 47(10):531-4. PubMed ID: 21798655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis.
    Weiss L; Reix P; Mosnier-Pudar H; Ronsin O; Beltrand J; Reynaud Q; Mely L; Burgel PR; Stremler N; Rakotoarisoa L; Galderisi A; Perge K; Bendelac N; Abely M; Kessler L
    Diabetes Metab; 2023 May; 49(3):101444. PubMed ID: 37030530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate metabolism impairment in children and adolescents with cystic fibrosis.
    Escudero García J; Martín Rivada Á; Uribe Posada A; Sanz Santiago V; Argente J; Martos-Moreno GÁ
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Oct; 69(8):576-583. PubMed ID: 36347795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis-Related Diabetes.
    Christian F; Thierman A; Shirley E; Allen K; Cross C; Jones K
    J Investig Med High Impact Case Rep; 2019; 7():2324709619842898. PubMed ID: 31010313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
    Ballmann M; Hubert D; Assael BM; Kronfeld K; Honer M; Holl RW;
    BMC Pediatr; 2014 Mar; 14():70. PubMed ID: 24620855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.
    Mozzillo E; Franzese A; Valerio G; Sepe A; De Simone I; Mazzarella G; Ferri P; Raia V
    Pediatr Diabetes; 2009 May; 10(3):162-7. PubMed ID: 19207231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of cystic fibrosis-related diabetes on health-related quality of life.
    Kwong E; Desai S; Chong L; Lee K; Zheng J; Wilcox PG; Quon BS
    J Cyst Fibros; 2019 Sep; 18(5):734-736. PubMed ID: 30935840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of diabetes in adult patients with cystic fibrosis].
    Robert JJ; Mosnier-Pudar H
    Rev Mal Respir; 2000 Aug; 17(3 Pt 2):798-801. PubMed ID: 11076389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance.
    Bizzarri C; Lucidi V; Ciampalini P; Bella S; Russo B; Cappa M
    J Endocrinol Invest; 2006 Mar; 29(3):RC1-4. PubMed ID: 16682829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.